AUTHOR AND EDITOR INFORMATION

Section 1 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

INTRODUCTION

Section 2 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

More than 20 million people in the United States have myopia between 1.00 and 3.00 diopters (D) with astigmatism of 1.00 D or less. Several options for visual rehabilitation are available to each individual, including spectacle correction, contact lens fitting, refractive keratotomy (RK), photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), and intracorneal rings or Intacs. Currently, nonsurgical approaches are still the least expensive and safest. For the subset of patients who desire freedom from glasses and lenses, refractive surgery is an option.

The ideal refractive surgery procedure is one that is effective, predictable, safe, and potentially reversible. The goal of this article is to introduce a refractive surgical procedure in which implantation of a polymethyl methacrylate (PMMA) ring or ring segments in the peripheral corneal stroma is used to correct myopia.

Device description

The intrastromal corneal ring (ICR) is a device designed to correct mild-to-moderate myopia by flattening the anterior corneal curvature without encroaching on the visual axis. The device is an open-ended PMMA transparent ring with an outer diameter (R2) of 8.1 mm and an inner diameter (R1) of 6.8 mm. It is precision lathe-cut to ±0.01 mm as a hexagonal-shaped section of a cone with positioning holes for manipulation. It is inserted through a peripheral radial incision made with a diamond knife at two-thirds corneal depth in to a 360° peripheral intrastromal channel created with specially designed instruments. Anterior corneal curvature is changed by using rings of different thicknesses.

Intrastromal corneal ring segments (Intacs microthin prescription inserts), or ICRS, are a more recent design modification of the ICR. The ring segments split the ring into two 150° arcs. The use of ring segments simplifies the implantation procedure. Furthermore, ring segments can be placed away from the radial incision, thereby minimizing the potential for incision-related complications. The degree of correction (greater-thicker) is determined by the thickness of the Intacs inserts, which are available in 5 sizes: 0.25 mm, 0.275 mm, 0.30 mm, 0.325 mm, and 0.35 mm.

Surgical instruments

Addition Technology has surgical instruments specifically for use with Intacs insertion. These instruments include the following: corneal thickness gauges, glides, incision and placement marker, pocketing hook, pocketing lever, ring forceps, stromal spreader, vacuum-centering guide with vacuum system, and clockwise and counterclockwise dissectors.

How do Intacs inserts work?

Imagine the cornea as compressed arcs of fiber covering the eye. If a spacer element is inserted between those fibers, effectively pushing them apart, then the arc must flatten to accommodate the inserted element. Intacs inserts shorten the corneal cord length, produce flattening across the entire cornea, and maintain the positive asphericity of the cornea.

Advantages of Intacs inserts

Several benefits of using Intacs microthin inserts exist. It is a minimally invasive outpatient procedure. Since the surgery is completed in the peripheral cornea, the central optical zone is not disturbed. Results are rapid and predictable. There is a reduced risk of visual side effects and a long-term convenient refractive correction. It is removable and exchangeable. Corneal asphericity (prolate) is maintained. Intacs may now be used to treat irregular steepening (irregular astigmatism) of the cornea caused by keratoconus.

Disadvantages of Intacs inserts

The technology is limited for use in low-to-moderate myopia with low astigmatism only. It is still a relatively new technology with emerging complications (eg, diurnal fluctuations in visual acuity, stromal opacifications). Of further concern is the prolonged intraoperative elevated intraocular pressure.

History of the Procedure

The KeraVision Ring was conceived by A.E. Reynolds, OD, in 1978. Kera Associates formed in 1980 to develop the ICR and other concepts. In 1995, the first preclinical study on Reynolds' product was performed.

In 1991, the first human clinical trials began in Brazil with 360° ICR. The rings were implanted in corneas of nonfunctional human eyes. Shortly thereafter, a similar study was performed in the United States. Implantation in sighted eyes in the United States was implemented in 1993 as part of a US Food and Drug Administration (FDA) regulated phase II study.

Implantation in contralateral eyes began in 1994. Preliminary astigmatism study began in Brazil at this time. In 1995, the US phase II myopia trial began for 150° ICRS. In 1996, the US phase III for -1.00 to -3.50 D of myopia began. CE (Conformite Europeene) marking was granted, permitting the commercial sale of the ICR in the European Union. A Pan-European myopia study began for ICRS. In 1998, HPB approval was granted in Canada, while preliminary hyperopia studies were started in Mexico.

A premarket approval (PMA) application was filed with the FDA. In 1999, the trade name Intacs inserts was adopted for commercial sales of the ICRS, and FDA approval was granted for the commercial sale of Intacs inserts for -1.00 to -3.00 D of myopia with less than -1.00 D of astigmatism in the United States. After a promising introduction into the refractive market, KeraVision, the maker of Intacs, experienced financial difficulties and eventually sold its assets to Addition Technology in April 2001. Since its introduction, however, the use of Intacs has expanded from the treatment of patients with low-to-moderate myopia with low astigmatism to the treatment of patients with keratoconus.

Table 1. Evolution of Intacs Inserts

INDICATIONS

Section 3 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

According to the FDA, Intacs are intended for the reduction or elimination of mild myopia (-1.00 to -3.00 D spherical equivalent at the spectacle plane) in patients who are aged 21 years or older, patients with documented stability of refraction as demonstrated by a change of less than or equal to 0.50 D for at least 12 months prior to the preoperative examination, and in patients where the astigmatic component is +1.00 D or less.

In 2004, Intacs was given humanitarian device approval by the FDA for use in patients with keratoconus. The inserts may now be used to reduce irregular steepening (irregular astigmatism) caused by keratoconus. Intacs inserts help restore clear vision in patients with keratoconus by flattening and repositioning the cornea. Intacs inserts are intended for patients with keratoconus who are no longer able to achieve adequate vision using contact lenses or glasses and for whom corneal transplantation is the only remaining option.

Table 2. The predicted nominal correction and recommended prescribing range for each Intacs thickness based on data from the US clinical trials

RELEVANT ANATOMY

Section 4 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

The cornea is a transparent, avascular tissue that is continuous with the opaque sclera and semitransparent conjunctiva. It is covered by tear film on its anterior surface and bathed by aqueous humor on its posterior surface. In adults, the cornea measures 11-12 mm horizontally and 9-11 mm vertically. The average corneal thickness is 0.5 mm (500 µm) centrally and 0.7 mm (700 µm) peripherally.

CONTRAINDICATIONS

Section 5 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Intacs are contraindicated in the following patients:

• Patients younger than 21 years, with stable refractive error
• Patients with existing collagen vascular, autoimmune, or immunodeficiency disease
• Women who are pregnant or breastfeeding
• Patients with previous anterior segment trauma
• In the presence of existing ocular conditions, such as recurrent corneal erosion syndrome, corneal dystrophy, or other corneal pathology that may predispose the patient to future complications
• Patients who are using one or more of the following medications: isotretinoin (Accutane), amiodarone (Cordarone), and/or sumatriptan (Imitrex)
• Patients with unrealistic expectations

Intacs should not be used in patients with keratoconus who

• can achieve functional vision on a daily basis by using contact lenses,
• are younger than 21 years,
• do not have clear central corneas, and
• have a corneal thickness of less than 450 µm at the proposed incision site.

Warnings include the following:

• Increased intraocular pressure results from the use of the vacuum-centering guide.
• The surgeon should limit continuous application of the vacuum to 3 minutes or less and to no more than 750 mBar. In some instances, reapplication of the vacuum may be necessary, and it is advised that a 5-minute "reperfusion" phase be allowed prior to reestablishing suction.
• It is not advisable to use Intacs in patients with systemic diseases likely to affect wound healing (eg, insulin-dependent diabetes, severe atopic disease).
• It is not advisable to use Intacs in patients with a history of ocular manifestations of herpes simplex virus or herpes zoster virus.
• Resterilization and/or reuse of Intacs are not recommended.

Precautions include the following:

• The use of thicker diameter (0.35 mm) ring segments is accompanied by a higher probability for a reduced outcome compared to the use of the thinner diameter (0.25-0.30 mm) ring segments. Dissatisfaction from the reduced outcomes may lead to a higher rate of removal of thicker diameter (0.35 mm) ring segments.
• Patients with myopia of -1.00 D carry the higher risk for overcorrection.
• The long-term effects of Intacs on endothelial cell counts have not yet been established. A temporary decrease in corneal sensations may occur in some patients. Patients with large scotopic pupils may experience some visual symptoms. They have to be properly advised. In some instances, some patients may experience a decrease in contrast sensitivity.
• No studies have been performed to establish the safety and effectiveness of other refractive procedures after the removal of Intacs.
• The safety and effectiveness of Intacs have not been established for the following:
• • Patients with progressive myopia or astigmatism, nuclear sclerosis or other crystalline lens opacity, corneal abnormality, or previous corneal surgery or trauma
  • Patients younger than 21 years
  • Corneas that are flatter than 40 D or steeper than 46 D
  • Corneas with a central thickness less than 480 µm or peripheral thickness less than 570 µm
  • Patients with greater than -3.50 D of myopia or with astigmatism greater than +1.00 D
  • In long-term use

WORKUP

Section 6 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Imaging Studies

• Corneal topography
• • Corneal topography development provides surgeons with effortlessly understood color-coded maps of corneal curvature in addition to quantitative indexes of irregular astigmatism that correlate with potential visual acuity.
  • Modern instrumentation produces a videokeratograph, which generally is in the form of a color-coded contour map.
  • Different manufacturers use different methods (Placido, 40 scanned slits, combination Placido and 40 scanned slits, phase modified laser holography, and raster stereography).
  • The use of video keratography in the preoperative and postoperative evaluation of all patients undergoing refractive surgery is valuable.

Other Tests

• Pachymetry
• • The pachymeter (optical, ultrasonic) is used to measure corneal thickness.
  • Accurate determination of corneal thickness preoperatively allows the surgeon to set the depth of incision to two thirds of the measured result.
  • Orbscan II by Orbtek uses both 40 scan slits and Placido methods to provide anterior and posterior corneal curvature in addition to data on corneal thickness.

TREATMENT

Section 7 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Medical therapy

Medical therapy is limited to broad-spectrum topical antibiotics and corticosteroids for uncomplicated cases. See Postoperative details and/or articles on ocular pharmacology for more information.

Surgical therapy

See Intraoperative details for the surgical procedure.

Preoperative details

The procedure for placement of the intrastromal ring and ring segments is similar, and both can be performed with topical anesthesia. The operative field is prepared, and the patient is prepared and draped in the usual sterile fashion for ophthalmic surgery. A lid speculum is used for globe exposure.

Intraoperative details

• The corneal center is identified and marked with a Sinskey hook.
• A 2-mm long epithelial impression is created at the 12-o'clock position, where the ring segments are to be placed at an 8-mm diameter optical zone.
• A diamond blade, set at 65% of the peripheral corneal depth, is used to perform a radial incision along this mark.
• A vacuum-centering guide is positioned relative to the central corneal indentation.
• The vacuum is increased, and the guide is circumferentially adhered onto the perilimbal conjunctiva, stabilizing the globe. This device provides a guide for the dissector. The dissector is inserted into the radial incision, and blunt dissection of the cornea at two-thirds depth is performed in the clockwise and counterclockwise directions to create 2 stromal channels.
• The vacuum is released, and the vacuum-centering guide is removed.
• Ring segments are inserted through the radial incisions using special forceps and are positioned using a Sinskey hook nasally and temporally, such that the superior ends are approximately 3 mm apart.
• The incision is closed with 1 or 2 interrupted 11-0 nylon sutures.

Postoperative details

Postoperatively, antibiotic-corticosteroid combination drops and/or ointment are used, and the speculum is removed. The eye may be covered overnight with a shield. Antibiotic-corticosteroid combination drops are used 4 times daily for 1 week. The sutures are removed 2 weeks postoperatively or longer if the incision is not healed adequately.

Follow-up

Patients are seen postoperatively on day 1, week 1, and months 1, 3, 6, and 12. The surgeon should watch for postoperative complications. An observations timeline has been outlined for potential complications. See Complications.

COMPLICATIONS

Section 8 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Complications include localized incision-related epithelial defects, epithelial plug formation, wound dehiscence, superficial neovascularization, surgically induced astigmatism, infiltrates in the channel, transient decreased corneal sensation, and delayed infectious keratitis. Other observations included haze and deposits around the intrastromal channel.

Observations timeline consists of the following:

• Immediate (1-7 d)
• Early (1-4 wk)
• Intermediate (after 4 wk)
• Immediate postoperative observations may include epithelial defects, lamellar channel haze, undercorrection and overcorrection, and incision-healing responses.
• Early postoperative observations may include sterile infiltrates, epithelial cysts or plugs, and infectious keratitis.
• Late postoperative observations may include positioning hole deposits, lamellar channel deposits, and infectious keratitis.

OUTCOME AND PROGNOSIS

Section 9 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

A summary of the safety and efficacy variables at 12 months after surgery is as follows:

• Uncorrected visual activity (UCVA) 20/20 or better (74%); UCVA 20/40 or better (97%)
• Mean refractive spherical equivalent (MRSE) ± 0.50 D (69%); MRSE ± 1.00 D (92%)
• Greater than or equal to 2 lines loss best spectacle corrected visual acuity (0%); increased cylinder greater than or equal to 2.00 D (0%)
• Corneal topography demonstrated that while general flattening of the central cornea occurs, the normal positive asphericity of the cornea is maintained after placement of ring and ring segments.
• Transient dry eye may follow the placement of Intacs inserts, but the tear film quality returns within 1 week after surgery.

FUTURE AND CONTROVERSIES

Section 10 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Future applications of Intacs microthin inserts technology include the following:

• Myopia with astigmatism - Going beyond the range that has been approved by the FDA; currently, the upper limit is at -3.00 D spherical equivalent at the spectacle plane.
• Astigmatism - Applications in patients with pure astigmatism; currently, the upper limit is at +1.00 D of astigmatism.
• Presbyopia - In presbyopes and patients previously treated with LASIK or PRK
• Therapeutic indications - The use of Intacs in patients with mild corneal ectasia not deemed to be candidates for LASIK or PRK
• Therapeutic indications - By flattening the central corneal protrusion, intracorneal ring implantation is a promising new therapy for patients with early-to-moderate pellucid marginal degeneration (PMD) and who are intolerant of contact lenses.
• Combination refractive procedures – Both the LASIK-Intacs method and the Intacs-LASIK method resulted in significant improvement in visual acuity and refraction based on limited experience. LASIK followed by Intacs may be the preferred procedure for reasons of safety, convenience, and lower induced cylinder.
• Enhancement - The correction of residual myopia following maximum corneal sculpting with LASIK or PRK (posterior stromal bed too thin for further ablation); improving the conditions of patients with decreased nighttime visual function (including halos, induced myopia, and decreased contrast sensitivity) following LASIK and PRK, associated with constricted optical zones
• Enhancement - Implantation of Intacs in eyes with myopic regression after LASIK and PRK resulted in a good refractive outcome and an improvement in uncorrected visual acuity.

MULTIMEDIA

Section 11 of 12  

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

Media file 1:  KeraVision Intacs microthin prescription inserts. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Photo

Media file 2:  KeraVision Intacs microthin prescription inserts. Intracorneal ring segments. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Photo

Media file 3:  The 1.2-mm radial incision is made with a diamond knife at the edge of a 7-mm optical zone. The diamond knife is set for approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Image

Media file 4:  Rotation of the dissector creates the tunnel in the peripheral cornea into which an Intacs insert will be placed. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Image

Media file 5:  The first Intacs insert is placed in the tunnel. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Image

Media file 6:  An Intacs insert in place at approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Image

Media file 7:  Graphic representation of the intracorneal ring segments in place. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Image

Media file 8:  Intacs microthin prescription inserts treat mild myopia. Reprinted with permission of Addition Technology Inc.
	View Full Size Image
Media type:  Photo

REFERENCES

Section 12 of 12

• Authors and Editors
• Introduction
• Indications
• RELEVANT ANATOMY
• Contraindications
• Workup
• Treatment
• Complications
• Outcome And Prognosis
• Future And Controversies
• Multimedia
• References

• Alio J, Salem T, Artola A. Intracorneal rings to correct corneal ectasia after laser in situ keratomileusis. J Cataract Refract Surg. Sep 2002;28(9):1568-74. [Medline].
• Alio JL, Artola A, Hassanein A. One or 2 Intacs segments for the correction of keratoconus. J Cataract Refract Surg. May 2005;31(5):943-53. [Medline].
• Asbell PA, Ucakhan OO, Durrie DS, Lindstrom RL. Adjustability of refractive effect for corneal ring segments. J Refract Surg. Nov-Dec 1999;15(6):627-31. [Medline].
• Asbell PA, Ucakhan OO. Long-term follow-up of Intacs from a single center. J Cataract Refract Surg. Sep 2001;27(9):1456-68. [Medline].
• Assil KK, Quantock AJ, Barrett AM, Schanzlin DJ. Corneal iron lines associated with the intrastromal corneal ring. Am J Ophthalmol. Sep 15 1993;116(3):350-6. [Medline].
• Assil KK, Barrett AM, Fouraker BD, Schanzlin DJ. One-year results of the intrastromal corneal ring in nonfunctional human eyes. Intrastromal Corneal Ring Study Group. Arch Ophthalmol. Feb 1995;113(2):159-67. [Medline].
• Assil KK. Intacs as an Enhancement Procedure. In: AAO Refractive Surgery Subspecialty Day Manual. 2000.
• Azar RG, Holdbrook MJ, Lemp M. Two-year corneal endothelial cell assessment following INTACS implantation. J Refract Surg. Sep-Oct 2001;17(5):542-8. [Medline].
• Baikoff G, Maia N, Poulhalec D, et al. [Diurnal variations of refraction and keratometry after intracorneal rings]. J Fr Ophtalmol. Mar 1999;22(2):169-75. [Medline].
• Barach D, Mortemousque B, Bertel F, et al. [Fluctuations in uncorrected visual acuity after refractive surgery using intra-stromal corneal rings]. J Fr Ophtalmol. Apr 1999;22(3):335-8. [Medline].
• Barbara A, Shehadeh-Masha''our R, Zvi F. Management of pellucid marginal degeneration with intracorneal ring segments. J Refract Surg. May-Jun 2005;21(3):296-8. [Medline].
• Barbara A, Shehadeh-Masha'our R, Garzozi HJ. Intacs after laser in situ keratomileusis and photorefractive keratectomy. J Cataract Refract Surg. Sep 2004;30(9):1892-5. [Medline].
• Bourcier T, Borderie V, Laroche L. Late bacterial keratitis after implantation of intrastromal corneal ring segments. J Cataract Refract Surg. Feb 2003;29(2):407-9. [Medline].
• Boxer Wachler BS, Christie JP, Chandra NS. Intacs for keratoconus. Ophthalmology. May 2003;110(5):1031-40. [Medline].
• Burris TE, Holmes-Higgin DK, Silvestrini TA. Lamellar intrastromal corneal tattoo for treating iris defects (artificial iris). Cornea. Mar 1998;17(2):169-73. [Medline].
• Burris TE. Intrastromal corneal ring technology: results and indications. Curr Opin Ophthalmol. Aug 1998;9(4):9-14. [Medline].
• Burris TE, Holmes-Higgin DK, Silvestrini TA, et al. Corneal asphericity in eye bank eyes implanted with the intrastromal corneal ring. J Refract Surg. Sep-Oct 1997;13(6):556-67. [Medline].
• Burris TE, Baker PC, Ayer CT, et al. Flattening of central corneal curvature with intrastromal corneal rings of increasing thickness: an eye-bank eye study. J Cataract Refract Surg. 1993;19 Suppl:182-7. [Medline].
• Burris TE, Ayer CT, Evensen DA, Davenport JM. Effects of intrastromal corneal ring size and thickness on corneal flattening in human eyes. Refract Corneal Surg. Jan-Feb 1991;7(1):46-50. [Medline].
• Chan SM, Khan HN. Reversibility and exchangeability of intrastromal corneal ring segments. J Cataract Refract Surg. Apr 2002;28(4):676-81. [Medline].
• Clinch TE, Lemp MA, Foulks GN. Removal of INTACS for myopia. Ophthalmology. Aug 2002;109(8):1441-6. [Medline].
• Cochener B, Le Floch-Savary G, Colin J. [Excimer photorefractive keratectomy (PRK) versus intrastromal corneal ring segments (ICRS) for correction of low myopia]. J Fr Ophtalmol. Sep 2000;23(7):663-78. [Medline].
• Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg. Aug 2000;26(8):1117-22. [Medline].
• Colin J, Cochener B, Savary G. INTACS inserts for treating keratoconus: one-year results. Ophthalmology. Aug 2001;108(8):1409-14. [Medline].
• Colin J, Velou S. Implantation of Intacs and a refractive intraocular lens to correct keratoconus. J Cataract Refract Surg. Apr 2003;29(4):832-4. [Medline].
• Colin J, Velou S. Utilization of refractive surgery technology in keratoconus and corneal transplants. Curr Opin Ophthalmol. Aug 2002;13(4):230-4. [Medline].
• Davis EA, Hardten DR, Lindstrom RL. Laser in situ keratomileusis after intracorneal rings. Report of 5 cases. J Cataract Refract Surg. Dec 2000;26(12):1733-41. [Medline].
• Donnenfeld ED. Intacs vs LASIK for Low Myopia. In: AAO Refractive Surgery Subspecialty Day Manual. 2000.
• Duffey RJ, Leaming D. U.S. trends in refractive surgery: 2001 International Society of Refractive Surgery Survey. J Refract Surg. Mar-Apr 2002;18(2):185-8. [Medline].
• Durrie DS, Vande Garde TL. LASIK enhancements. Int Ophthalmol Clin. Summer 2000;40(3):103-10. [Medline].
• Edelhauser HF. The resiliency of the corneal endothelium to refractive and intraocular surgery. Cornea. May 2000;19(3):263-73. [Medline].
• FDA. Intacs. Summary of safety and effectiveness. FDA;1999.
• Fleming JF, Lovisolo CF. Intrastromal corneal ring segments in a patient with previous laser in situ keratomileusis. J Refract Surg. May-Jun 2000;16(3):365-7. [Medline].
• Fleming JF, Wan WL, Schanzlin DJ. The theory of corneal curvature change with the Intrastromal Corneal Ring. CLAO J. Apr-Jun 1989;15(2):146-50. [Medline].
• Gomez L, Chayet A. Laser in situ keratomileusis results after intrastromal corneal ring segments (Intacs). Ophthalmology. Oct 2001;108(10):1738-43. [Medline].
• Grabner G, Ruckhofer J, Tratter C, Alzner E. [The intrastromal corneal ring (KeraVision Ring, ICR, ICRS). A modern method for correcting minor myopia]. Wien Med Wochenschr. 1997;147(12-13):309-21. [Medline].
• Guell JL. Are intracorneal rings still useful in refractive surgery?. Curr Opin Ophthalmol. Aug 2005;16(4):260-5. [Medline].
• Guell JL, Velasco F, Sanchez SI. Intracorneal ring segments after laser in situ keratomileusis. J Refract Surg. Jul-Aug 2004;20(4):349-55. [Medline].
• Harr D. KeraVision begins implanting corneal reshaping device in blind eyes. Refract Corneal Surg. Sep-Oct 1991;7(5):343. [Medline].
• Hellstedt T, Makela J, Uusitalo R. Treating keratoconus with Intacs corneal ring segments. J Refract Surg. May-Jun 2005;21(3):236-46. [Medline].
• Hofling-Lima AL, Branco BC, Romano AC. Corneal infections after implantation of intracorneal ring segments. Cornea. Aug 2004;23(6):547-9. [Medline].
• Holmes-Higgin DK, Burris TE. Corneal surface topography and associated visual performance with INTACS for myopia: phase III clinical trial results. The INTACS Study Group. Ophthalmology. Nov 2000;107(11):2061-71. [Medline].
• Holmes-Higgin DK, Baker PC, Burris TE, Silvestrini TA. Characterization of the aspheric corneal surface with intrastromal corneal ring segments. J Refract Surg. Sep-Oct 1999;15(5):520-8. [Medline].
• Holmes-Higgin DK, Burris TE, Lapidus JA. Risk factors for self-reported visual symptoms with Intacs inserts for myopia. Ophthalmology. Jan 2002;109(1):46-56. [Medline].
• Ito M, Arai H, Fukumoto T. INTACS before or after laser in situ keratomileusis: correction of thin corneas with moderately high myopia. J Refract Surg. Nov-Dec 2004;20(6):818-22. [Medline].
• Kessler D, El-Shiaty AF, Wachler BS. Evaluation of tear film following Intacs for myopia. J Refract Surg. Mar-Apr 2002;18(2):127-9. [Medline].
• Kymionis GD, Aslanides IM, Siganos CS. Intacs for early pellucid marginal degeneration. J Cataract Refract Surg. Jan 2004;30(1):230-3. [Medline].
• Kymionis GD, Siganos CS, Kounis G. Management of post-LASIK corneal ectasia with Intacs inserts: one-year results. Arch Ophthalmol. Mar 2003;121(3):322-6. [Medline].
• Levinger S, Pokroy R. Keratoconus managed with Intacs: one-year results. Arch Ophthalmol. Oct 2005;123(10):1308-14. [Medline].
• Linebarger EJ, Song D, Ruckhofer J, Schanzlin DJ. Intacs: the intrastromal corneal ring. Int Ophthalmol Clin. Summer 2000;40(3):199-208. [Medline].
• Loarie TM. The migration offshore of U.S. medical technology innovation--what it means for U.S. physicians. J Refract Surg. Mar-Apr 1997;13(2):176-84. [Medline].
• Loughnan MS, Robinson D, Sullivan L. Mechanical methods in refractive corneal surgery. Curr Opin Ophthalmol. Aug 1996;7(4):41-6. [Medline].
• Lovisolo CF, Fleming JF. Intracorneal ring segments for iatrogenic keratectasia after laser in situ keratomileusis or photorefractive keratectomy. J Refract Surg. Sep-Oct 2002;18(5):535-41. [Medline].
• McDonald JE, Deitz DJ. Removal of Intacs with a fractured positioning hole. J Refract Surg. Mar-Apr 2004;20(2):182-3. [Medline].
• Mularoni A, Torreggiani A, di Biase A. Conservative treatment of early and moderate pellucid marginal degeneration: a new refractive approach with intracorneal rings. Ophthalmology. Apr 2005;112(4):660-6. [Medline].
• Nio YK, Jansonius NM, Wijdh RH. Effect of methods of myopia correction on visual acuity, contrast sensitivity, and depth of focus. J Cataract Refract Surg. Nov 2003;29(11):2082-95. [Medline].
• Nose W, Neves RA, Schanzlin DJ, Belfort Junior R. Intrastromal corneal ring--one-year results of first implants in humans: a preliminary nonfunctional eye study. Refract Corneal Surg. Nov-Dec 1993;9(6):452-8. [Medline].
• Nose W, Neves RA, Burris TE, et al. Intrastromal corneal ring: 12-month sighted myopic eyes. J Refract Surg. Jan-Feb 1996;12(1):20-8. [Medline].
• Patel S, Marshall J, Fitzke FW 3rd. Model for deriving the optical performance of the myopic eye corrected with an intracorneal ring. J Refract Surg. Jul-Aug 1995;11(4):248-52. [Medline].
• Pokroy R, Levinger S, Hirsh A. Single Intacs segment for post-laser in situ keratomileusis keratectasia. J Cataract Refract Surg. Aug 2004;30(8):1685-95. [Medline].
• Quantock AJ, Assil KK, Schanzlin DJ. Electron microscopic evaluation of intrastromal corneal rings explanted from nonfunctional human eyes. J Refract Corneal Surg. Mar-Apr 1994;10(2):142-8. [Medline].
• Rapuano CJ, Sugar A, Koch DD. Intrastromal corneal ring segments for low myopia: a report by the American Academy of Ophthalmology. Ophthalmology. Oct 2001;108(10):1922-8. [Medline].
• Rodriguez-Prats J, Galal A, Garcia-Lledo M. Intracorneal rings for the correction of pellucid marginal degeneration. J Cataract Refract Surg. Jul 2003;29(7):1421-4. [Medline].
• Rosen E, Kowalewski E. Instrument for initiating the corneal intrastromal channel for the insertion of Intacs. J Cataract Refract Surg. Sep 2001;27(9):1356-8. [Medline].
• Ruckhofer J, Bohnke M, Alzner E, Grabner G. Confocal microscopy after implantation of intrastromal corneal ring segments. Ophthalmology. Dec 2000;107(12):2144-51. [Medline].
• Ruckhofer J, Twa MD, Schanzlin DJ. Clinical characteristics of lamellar channel deposits after implantation of Intacs. J Cataract Refract Surg. Oct 2000;26(10):1473-9. [Medline].
• Ruckhofer J, Linebarger EJ, Schanzlin DJ. Goldmann applanation tonometry after Intacs corneal ring segments(1). J Cataract Refract Surg. Sep 2000;26(9):1332-8. [Medline].
• Schanzlin DJ, Asbell PA, Burris TE, Durrie DS. The intrastromal corneal ring segments. Phase II results for the correction of myopia. Ophthalmology. Jul 1997;104(7):1067-78. [Medline].
• Shehadeh-Masha'our R, Modi N, Barbara A. Keratitis after implantation of intrastromal corneal ring segments. J Cataract Refract Surg. Aug 2004;30(8):1802-4. [Medline].
• Siganos CS, Kymionis GD, Kartakis N. Management of keratoconus with Intacs. Am J Ophthalmol. Jan 2003;135(1):64-70. [Medline].
• Siganos CS, Kymionis GD, Astyrakakis N. Management of corneal ectasia after laser in situ keratomileusis with INTACS. J Refract Surg. Jan-Feb 2002;18(1):43-6. [Medline].
• Sugar A. Correction of spherical myopia with a single 150-degree intrastromal corneal ring segment. J Cataract Refract Surg. May 2004;30(5):1127-9. [Medline].
• Tran DB, Zadok D, Carpenter M, et al. Intraocular pressure measurement in patients with intrastromal corneal ring segments. J Refract Surg. Jul-Aug 1999;15(4):441-3. [Medline].
• Twa MD, Hurst TJ, Walker JG, et al. Diurnal stability of refraction after implantation with intracorneal ring segments. J Cataract Refract Surg. Apr 2000;26(4):516-23. [Medline].
• Twa MD, Karpecki PM, King BJ, et al. One-year results from the phase III investigation of the KeraVision Intacs. J Am Optom Assoc. Aug 1999;70(8):515-24. [Medline].
• Ucakhan OO, Tello C, Liebmann JM. Optical coherence tomography of Intacs. J Cataract Refract Surg. Oct 2001;27(10):1535. [Medline].

Article Last Updated: Jan 6, 2006